Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-03-29

Clinical Trial Update: Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial on therapeutic drug monitoring and continuous infusion of beta-lactam antibiotics for bacteremia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sara Thønnings | Conditions: Bacteremia | Phase 4 | Status: WITHDRAWN